https://scholars.lib.ntu.edu.tw/handle/123456789/631868
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Sunami, Kazutaka | en_US |
dc.contributor.author | Ikeda, Takashi | en_US |
dc.contributor.author | SHANG-YI HUANG | en_US |
dc.contributor.author | Wang, Ming-Chung | en_US |
dc.contributor.author | Koh, Youngil | en_US |
dc.contributor.author | Min, Chang Ki | en_US |
dc.contributor.author | Yeh, Su-Peng | en_US |
dc.contributor.author | Matsumoto, Morio | en_US |
dc.contributor.author | Uchiyama, Michihiro | en_US |
dc.contributor.author | Iyama, Satoshi | en_US |
dc.contributor.author | Shimazaki, Chihiro | en_US |
dc.contributor.author | Lee, Jae Hoon | en_US |
dc.contributor.author | Kim, Kihyun | en_US |
dc.contributor.author | Kaneko, Hitomi | en_US |
dc.contributor.author | Kim, Jin Seok | en_US |
dc.contributor.author | Lin, Tung-Liang | en_US |
dc.contributor.author | Campana, Frank | en_US |
dc.contributor.author | Tada, Keisuke | en_US |
dc.contributor.author | Iida, Shinsuke | en_US |
dc.contributor.author | Suzuki, Kenshi | en_US |
dc.date.accessioned | 2023-06-07T03:34:29Z | - |
dc.date.available | 2023-06-07T03:34:29Z | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 2152-2650 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/631868 | - |
dc.description.abstract | In the pivotal phase III, randomized, multicenter ICARIA-MM study (NCT02990338), isatuximab plus pomalidomide and dexamethasone (Isa-Pd) improved progression-free survival and overall response rate versus pomalidomide and dexamethasone (Pd) in the overall population of patients with relapsed/refractory multiple myeloma. | en_US |
dc.language.iso | en | en_US |
dc.publisher | CIG MEDIA GROUP, LP | en_US |
dc.relation.ispartof | Clinical lymphoma, myeloma & leukemia | en_US |
dc.subject | Efficacy and safety; Far East; Isa-Pd; Japan; RRMM | en_US |
dc.title | Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.clml.2022.04.005 | - |
dc.identifier.pmid | 35641409 | - |
dc.identifier.scopus | 2-s2.0-85131126183 | - |
dc.identifier.isi | WOS:000834076800010 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85131126183 | - |
dc.relation.pages | E751 | en_US |
dc.relation.journalvolume | 22 | en_US |
dc.relation.journalissue | 8 | en_US |
dc.relation.pageend | e761 | en_US |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0001-5688-3410 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。